MBX-102/JNJ39659100, a Novel Non-TZD Selective Partial PPAR- Agonist Lowers Triglyceride Independently of PPAR- Activation
Figure 7
Effect
of PPAR- agonists, rosiglitazone, pioglitazone, and MBX-102 acid on HADHB (a), HMGCS2 (b), and CYP4a11 (c) mRNA
levels in primary human hepatocytes. Values represent
mean SEM
(: , : versus Vehicle-treated, 1-way ANOVA and Tukey's
multiple comparison test).
